Coalition pour de meilleurs médicaments / Best Medicines Coalition
Enregistrement :
51
de
55
(2023-08-02
à
2024-01-09)
Politique ou Programme
Ensure access to a comprehensive range of medicines and vaccines in Canada and protect access to clinical trials, while helping to rebuild domestic capacities to develop and make drugs and vaccines.
Ensure patient organizations are consulted and provide feedback during the proposed creation of the Canadian Drug Agency as outlined in Budget 2019.
Learn more about and provide feedback on plans around COVID-19 vaccines.
Provide input on a national strategy for drugs for rare diseases.
Politique ou Programme, Proposition législative, Projet de loi ou résolution
Share patient groups perspectives on national pharmacare and national formulary proposals.
Politique ou Programme, Règlement
Discuss Canada's response to the proposed bulk importation of medications from Canada to the United States.
Recommend that the government and regulators adopt proactive approaches to communicating drug supply and shortages issues and measures to address them.
Share patient groups perspectives on drug pricing and access to medications/vaccines/clinical trials, specifically regulations and guidelines related to the Patented Medicine Prices Review Board, along with feedback on their policies and practices, and processes related to PMPRB.
Politique ou Programme, Subvention, Contribution ou autre avantage financier
Recommend that the government study and provide public interest funding so that the voices of patients, their needs and interests can be more adequately represented in public policy and regulatory matters.
Règlement
Provide input on proposed agile regulations and guidance for licensing drugs and medical devices.